Given the cell-type–specific role of HIF-1 in gut barrier function, it will be interesting to examine the effects of gain- and loss of HIF-1α in the different cell types of intestine in the context of MASLD. Here, HIF1A is linked to metabolic dysfunction-associated steatotic liver disease.